Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | ANNUAL REPORT | ea0200564-10k_longeveron.htm iXBRL | 10-K | 2067149 |
| 2 | DESCRIPTION OF REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE | ea0200564ex4-2_longeveron.htm | EX-4.2 | 36938 |
| 3 | SEPARATION AGREEMENT AND GENERAL RELEASE, EFFECTIVE JUNE 9, 2023, BY AND BETWEEN | ea0200564ex10-5i_longeveron.htm | EX-10.5(1) | 46161 |
| 4 | SEPARATION AGREEMENT AND GENERAL RELEASE, EFFECTIVE MARCH 31, 2023 BETWEEN LONGE | ea0200564ex10-13i_longeveron.htm | EX-10.13(1) | 44461 |
| 5 | EMPLOYMENT AGREEMENT BETWEEN LONGEVERON INC. AND PAUL LEHR DATED MAY 3, 2022 | ea0200564ex10-15_longeveron.htm | EX-10.15 | 98090 |
| 6 | LETTER AGREEMENT BETWEEN LONGEVERON, INC. AND LISA LOCKLEAR, DATED JULY 14,2023 | ea0200564ex10-16_longeveron.htm | EX-10.16 | 56367 |
| 7 | LETTER AGREEMENT BETWEEN LONGEVERON, INC. AND NATALIYA AGAFONOVA, M.D. DATED JUN | ea0200564ex10-17_longeveron.htm | EX-10.17 | 58563 |
| 8 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ea0200564ex23-1_longeveron.htm | EX-23.1 | 2160 |
| 9 | CERTIFICATION | ea0200564ex31-1_longeveron.htm | EX-31.1 | 9523 |
| 10 | CERTIFICATION | ea0200564ex31-2_longeveron.htm | EX-31.2 | 9282 |
| 11 | CERTIFICATION | ea0200564ex32-1_longeveron.htm | EX-32.1 | 3420 |
| 12 | CERTIFICATION | ea0200564ex32-2_longeveron.htm | EX-32.2 | 3416 |
| 13 | POLICY RELATING TO RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION | ea0200564ex97-1_longeveron.htm | EX-97.1 | 28132 |
| 19 | GRAPHIC | image_001.jpg | GRAPHIC | 1540 |
| 20 | GRAPHIC | image_002.jpg | GRAPHIC | 1558 |
| 21 | GRAPHIC | image_003.jpg | GRAPHIC | 1706 |
| 22 | GRAPHIC | ex10-16_001.jpg | GRAPHIC | 1705 |
| 23 | GRAPHIC | ex10-17_001.jpg | GRAPHIC | 2616 |
| 24 | GRAPHIC | ex10-15_001.jpg | GRAPHIC | 370209 |
| 25 | GRAPHIC | ex10-15_002.jpg | GRAPHIC | 358524 |
| 26 | GRAPHIC | ex10-15_003.jpg | GRAPHIC | 310119 |
| 27 | GRAPHIC | ex10-15_004.jpg | GRAPHIC | 409159 |
| 28 | GRAPHIC | ex10-15_005.jpg | GRAPHIC | 297758 |
| 29 | GRAPHIC | ex10-15_006.jpg | GRAPHIC | 352593 |
| 30 | GRAPHIC | ex10-15_007.jpg | GRAPHIC | 406291 |
| 31 | GRAPHIC | ex10-15_008.jpg | GRAPHIC | 366633 |
| 32 | GRAPHIC | ex10-15_009.jpg | GRAPHIC | 388816 |
| 33 | GRAPHIC | ex10-15_010.jpg | GRAPHIC | 346215 |
| 34 | GRAPHIC | ex10-15_011.jpg | GRAPHIC | 332907 |
| 35 | GRAPHIC | ex10-15_012.jpg | GRAPHIC | 346853 |
| 36 | GRAPHIC | ex10-15_013.jpg | GRAPHIC | 351013 |
| 37 | GRAPHIC | ex10-15_014.jpg | GRAPHIC | 373784 |
| 38 | GRAPHIC | ex10-15_015.jpg | GRAPHIC | 398629 |
| 39 | GRAPHIC | ex10-15_016.jpg | GRAPHIC | 84028 |
| 40 | GRAPHIC | ex10-15_017.jpg | GRAPHIC | 82610 |
| 41 | GRAPHIC | ex10-15_018.jpg | GRAPHIC | 261624 |
| 42 | GRAPHIC | ex10-15_019.jpg | GRAPHIC | 407468 |
| 43 | GRAPHIC | ex10-15_020.jpg | GRAPHIC | 371740 |
| 44 | GRAPHIC | ex10-15_021.jpg | GRAPHIC | 310170 |
| 45 | GRAPHIC | ex10-15_022.jpg | GRAPHIC | 369731 |
| 46 | GRAPHIC | ex10-15_023.jpg | GRAPHIC | 361472 |
| 47 | GRAPHIC | ex10-15_024.jpg | GRAPHIC | 314096 |
| 48 | GRAPHIC | ex10-15_025.jpg | GRAPHIC | 43035 |
| 49 | GRAPHIC | ex10-15_026.jpg | GRAPHIC | 67469 |
| Complete submission text file | 0001213900-24-017521.txt | 19115530 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 14 | XBRL SCHEMA FILE | lgvn-20231231.xsd | EX-101.SCH | 52973 |
| 15 | XBRL CALCULATION FILE | lgvn-20231231_cal.xml | EX-101.CAL | 45430 |
| 16 | XBRL DEFINITION FILE | lgvn-20231231_def.xml | EX-101.DEF | 336184 |
| 17 | XBRL LABEL FILE | lgvn-20231231_lab.xml | EX-101.LAB | 549276 |
| 18 | XBRL PRESENTATION FILE | lgvn-20231231_pre.xml | EX-101.PRE | 332822 |
| 120 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0200564-10k_longeveron_htm.xml | XML | 595489 |
IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40060 | Film No.: 24686518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
